Tag: entrepreneurs
-
Self-Adjusting Lenses Designed for Eyeglasses
An engineering lab at University of Utah developed a system with eyeglass lenses that automatically adjust to the focus of the wearer, to replace bifocals and reading glasses.
-
Allergy Immunotherapy Firm Raises $2M in Early Funds
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round.
-
Neuro Device Company to Begin Clinical Trials in Europe
Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders.
-
Univ. Spin-Off Develops Lower Cost 3-D Metal Printing
A spin-off enterprise from University at Buffalo engineering school developed a machine that produces lower-cost aluminum parts with three-dimensional liquid metal printing.
-
MD Anderson, Investment Firm Create Cancer Start-Up
MD Anderson Cancer Center and health care investment enterprise Deerfield Management are starting a new company to develop treatments for cancer that tackle processes feeding tumor growth.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Technique Uses Light to Activate Drugs in Blood Cells
A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Smartphone System Shown to Control Blood Glucose Levels
A bionic pancreas system using a smartphone was shown in a clinical trial to control blood glucose levels better than a commercial insulin pump in persons with type 1 diabetes.
-
Spin-Off Creates Enzyme to Prevent Celiac Disease
A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease.